Taken together, inhibition of pro-inflammatory cytokines including IL-1β andTNF-α as well as reduction of the Th2 cytokine IL-13 level might be effective against the overall stages of AD [32, 33]. The gene discussed is IL13; the disease is Alzheimer disease.